Skip to main content Skip to footer

AGILE trial reports on antiviral activity of molnupiravir in vaccinated and unvaccinated individuals infected with contemporaneous variants of SARS-CoV-2

The antiviral drug molnupiravir received regulatory approval for treating people … Continued

First antiviral pill to treat Covid-19 approved in UK

A “game-changing” antiviral pill that is part of the AGILE … Continued

People across the south to be part of pioneering research in the fight against COVID-19

People across the south are being asked to play their part in helping vital research into new COVID-19 treatments.
A ground-breaking clinical trial platform being led by researchers at the Southampton Clinical Trials Unit is now recruiting patients through the NIHR Southampton Clinical Research Facility within the General Hospital.